Maitra Amarnath, Shen Fang, Hanel Walter, Mossman Karen, Tocker Joel, Swart David, Gaffen Sarah L
Department of Oral Biology, University at Buffalo, State University of New York, Buffalo, NY 14214, USA.
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7506-11. doi: 10.1073/pnas.0611589104. Epub 2007 Apr 24.
IL-17 is the founding member of a novel family of proinflammatory cytokines that defines a new class of CD4+ effector T cells, termed "Th17." Mounting evidence suggests that IL-17 and Th17 cells cause pathology in autoimmunity, but little is known about mechanisms of IL-17RA signaling. IL-17 through its receptor (IL-17RA) activates genes typical of innate immune cytokines, such as TNFalpha and IL-1beta, despite minimal sequence similarity in their respective receptors. A previous bioinformatics study predicted a subdomain in IL-17-family receptors with homology to a Toll/IL-1R (TIR) domain, termed the "SEFIR domain." However, the SEFIR domain lacks motifs critical for bona fide TIR domains, and its functionality was never verified. Here, we used a reconstitution system in IL-17RA-null fibroblasts to map functional domains within IL-17RA. We demonstrate that the SEFIR domain mediates IL-17RA signaling independently of classic TIR adaptors, such as MyD88 and TRIF. Moreover, we identified a previously undescribed"TIR-like loop" (TILL) required for activation of NF-kappaB, MAPK, and up-regulation of C/EBPbeta and C/EBPdelta. Mutagenesis of the TILL domain revealed a site analogous to the LPS(d) mutation in TLR4, which renders mice insensitive to LPS. However, a putative salt bridge typically found in TIR domains appears to be dispensable. We further identified a C-terminal domain required for activation of C/EBPbeta and induction of a subset IL-17 target genes. This structure-function analysis of a IL-17 superfamily receptor reveals important differences in IL-17RA compared with IL-1/TLR receptors.
白细胞介素-17(IL-17)是一类促炎性细胞因子新家族的创始成员,该家族定义了一类新的CD4+效应T细胞,称为“Th17”。越来越多的证据表明,IL-17和Th17细胞在自身免疫性疾病中引发病理变化,但关于IL-17RA信号传导机制却知之甚少。尽管IL-17与其各自受体的序列相似性极小,但它通过其受体(IL-17RA)激活先天性免疫细胞因子典型的基因,如肿瘤坏死因子α(TNFα)和白细胞介素-1β(IL-1β)。先前的一项生物信息学研究预测,IL-17家族受体中有一个与Toll/IL-1受体(TIR)结构域具有同源性的亚结构域,称为“SEFIR结构域”。然而,SEFIR结构域缺乏真正TIR结构域所必需的基序,其功能也从未得到验证。在此,我们利用IL-17RA基因缺失的成纤维细胞中的重组系统来绘制IL-17RA内的功能结构域。我们证明,SEFIR结构域独立于经典的TIR衔接蛋白(如髓样分化因子88(MyD88)和TIR结构域衔接蛋白诱导干扰素β(TRIF))介导IL-17RA信号传导。此外,我们鉴定出一个以前未描述的“TIR样环”(TILL),它是激活核因子κB(NF-κB)、丝裂原活化蛋白激酶(MAPK)以及上调C/EBPβ和C/EBPδ所必需的。TILL结构域的诱变揭示了一个与Toll样受体4(TLR4)中的LPS(d)突变类似的位点,该突变使小鼠对脂多糖(LPS)不敏感。然而,通常在TIR结构域中发现的一个假定盐桥似乎是可有可无的。我们还鉴定出一个激活C/EBPβ和诱导一部分IL-17靶基因所必需的C末端结构域。对IL-17超家族受体的这种结构-功能分析揭示了IL-17RA与IL-1/TLR受体相比的重要差异。